Europe Single Cell Sequencing Market (2025-2030)
The Europe Single Cell Sequencing Market was valued at $369.2 Million in 2025 and projected to reach to $626.9 Million by 2030, representing a compound annual growth rate of 11.2%. Europe's single cell sequencing market is positioned for sustained growth driven by robust investments in genomic research infrastructure and precision medicine initiatives across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Single Cell Sequencing Market Trends and Insights
- This 11.2% compound annual growth rate reflects Europe's strong investment in genomic research infrastructure and precision medicine initiatives.
- Europe is leveraging advanced sequencing technologies to drive innovation in cancer research, immunology, and developmental biology, positioning the region as a key hub for single-cell analysis applications. The European market benefits from well-established healthcare systems, substantial R&D funding, and collaborative research networks across academic and commercial institutions.
- Between 2025 and 2030, Europe is expected to see increased adoption of single cell sequencing in clinical diagnostics and drug discovery.
- Regulatory support and growing awareness of personalized medicine are accelerating market penetration across Western and Central European countries, making Europe a critical growth region for single cell sequencing technologies..
Key Market Statistics
- CAGR (2025-2030) 11.2% CAGR
- Market Size, 2025 ~USD 369.2 Million
- Forecast, 2030 ~USD 626.9 Million
- Geography Europe
Europe Single Cell Sequencing Market Overview
Market Valuation & Growth :
Europe's single cell sequencing market is valued at $369.2 million in 2025, with a projected expansion to $626.9 million by 2030, representing an 11.2% CAGR. This growth trajectory underscores Europe's commitment to advancing genomic research capabilities.
Research Infrastructure Investment :
European nations are significantly investing in genomic research infrastructure and precision medicine initiatives. Leading countries like Germany ($237.3M) and the UK ($186.5M) are driving innovation through state-of-the-art sequencing facilities and collaborative research networks.
Cancer & Immunology Focus :
Europe is leveraging advanced single cell sequencing technologies to accelerate breakthroughs in cancer research and immunotherapy development. This focus aligns with the region's strategic priorities in personalized medicine and targeted therapeutic interventions.
Regulatory & Clinical Adoption :
Strong regulatory frameworks and clinical adoption across European healthcare systems are facilitating the integration of single cell sequencing into diagnostic and research workflows, supporting market expansion and technology standardization.
Europe Single Cell Sequencing Market Dynamics
- The 11.2% CAGR reflects increasing adoption of advanced sequencing technologies in academic institutions, research centers, and clinical laboratories, particularly in cancer genomics and immunology applications. Key European markets including Germany, the UK, and France are establishing themselves as innovation hubs, supported by favorable regulatory environments and collaborative research ecosystems.
- Continued funding from EU research programs, growing demand for personalized medicine, and technological advancements in sequencing platforms are expected to propel market expansion through 2030, positioning Europe as a critical hub for single cell genomics research and clinical applications..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Europe's single cell sequencing market is valued at $369.2 million in 2025 and will reach $626.9 million by 2030, growing at 11.2% CAGR.
- Europe leads in precision medicine adoption, with strong R&D infrastructure supporting single cell sequencing applications in cancer and immunology research.
- Regulatory frameworks and collaborative research networks across Europe are accelerating clinical adoption and commercialization of single cell technologies.
- Between 2025 and 2030, Europe will see significant expansion in drug discovery and diagnostic applications, driven by personalized medicine initiatives.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
Europe Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 154.3 | 154.9 | 157.6 | 166.8 | 182 | 203.8 | 232.6 | 270 | 11.4 |
| CROS | 35.5 | 35.2 | 35.3 | 36.9 | 39.8 | 43.9 | 49.5 | 56.6 | 9.9 |
| HOSPITALS & CLINICAL LABORATORIES | 69.3 | 69 | 69.6 | 73 | 79.1 | 87.7 | 99.3 | 114.3 | 10.4 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 103.9 | 104.6 | 106.8 | 113.4 | 124.1 | 139.4 | 159.7 | 185.9 | 11.7 |
| TOTAL | 363 | 363.8 | 369.2 | 390.1 | 425 | 474.8 | 541.1 | 626.9 | 11.2 |
REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 12.2 | 13.8 | 14.8 | 16.4 | 18.6 | 21.5 | 25.4 | 30.8 | 15.8 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 10.3 | 11.7 | 12.7 | 14.2 | 16.2 | 18.8 | 22.4 | 27.3 | 16.5 |
| HOSPITALS & CLINICAL LABORATORIES | 6.8 | 7.6 | 8 | 8.7 | 9.7 | 11 | 12.7 | 15.1 | 13.5 |
| TOTAL | 29.3 | 33.1 | 35.5 | 39.4 | 44.4 | 51.3 | 60.6 | 73.2 | 15.5 |
Target Audience
- Genomics & Sequencing Companies : Manufacturers and service providers of single cell sequencing platforms need European market data to optimize product positioning, identify key customer segments, and develop region-specific commercialization strategies.
- Research Institutions & Universities : European academic centers and research organizations require market insights to benchmark their capabilities, identify funding opportunities, and align research initiatives with market demand and technological trends.
- Healthcare & Diagnostic Providers : Clinical laboratories and diagnostic companies need comprehensive market analysis to evaluate single cell sequencing integration opportunities, assess competitive positioning, and plan service expansion across European markets.
- Investment & Private Equity Firms : Investors targeting the European genomics sector require detailed market sizing, growth projections, and country-specific insights to identify promising investment opportunities and assess portfolio company potential.
- Pharmaceutical & Biotech Companies : Drug developers and biotech firms need European single cell sequencing market data to inform precision medicine strategies, identify collaboration partners, and support clinical development and personalized therapy initiatives.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| UK | USD 186.5 Million |
| Germany | USD 237.3 Million |
| France | USD 91.6 Million |
| Italy | USD 37.7 Million |
| Spain | USD 25.4 Million |
| Rest Of Europe | USD 174.3 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Segmentation : Access detailed market sizing for major European markets including Germany, UK, France, Italy, and Spain, enabling precise regional investment and expansion strategies tailored to specific country dynamics.
- Competitive Landscape Intelligence : Understand market positioning across Europe's leading research institutions and commercial players, identifying partnership opportunities and competitive advantages in the rapidly evolving single cell sequencing sector.
- Technology Adoption Trends : Gain insights into adoption patterns of single cell sequencing technologies across European clinical and research settings, informing product development and market entry strategies for healthcare innovators.
- Regulatory & Reimbursement Insights : Analyze European regulatory frameworks and reimbursement policies affecting single cell sequencing adoption, critical for navigating market entry and scaling operations across multiple European jurisdictions.
- Growth Opportunity Identification : Identify high-growth segments and emerging applications in cancer research, immunotherapy, and personalized medicine within Europe, supporting strategic investment and R&D prioritization decisions.
Frequently asked questions
What is the current size of Europe's single cell sequencing market?
Europe's single cell sequencing market is valued at $369.2 million in 2025 and is projected to grow to $626.9 million by 2030.
What is the growth rate for single cell sequencing in Europe?
Europe's single cell sequencing market is growing at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2030.
Which applications are driving Europe's single cell sequencing market?
Europe's market is driven by applications in cancer research, immunology, developmental biology, drug discovery, and clinical diagnostics within precision medicine frameworks.
How does Europe's single cell sequencing market compare to global trends?
Europe's 11.2% CAGR is slightly below the global 12.2% CAGR, but Europe maintains a significant market share due to advanced healthcare infrastructure and R&D investment.
What factors are supporting growth in Europe's single cell sequencing market?
Growth is supported by strong R&D funding, regulatory support for precision medicine, collaborative research networks, and increasing adoption in clinical diagnostics and drug discovery.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
